- Looking to the past eradication of diseases, a new paper argues that the global eradication of COVID-19 is possible.
- The paper quantifies the factors affecting eradicability and scores a few diseases accordingly.
- The authors of the paper hope and believe that the international disruption that COVID-19 has caused may drive the world’s governments toward a global solution.
As wealthier nations struggle to get more people to undergo vaccination, lower income nations struggle to acquire sufficient vaccine doses, and new SARS-CoV-2 variants emerge, a newly published paper states that the global eradication of COVID-19 remains possible nonetheless.
Lead author of the paper, Dr. Nick Wilson of the University of Otago in Wellington, New Zealand, pointed out to Medical News Today that skepticism regarding the paper’s conclusion is not surprising:
“[The] reaction is completely understandable at the current point in time, [but] when the plans to eradicate smallpox were announced, and there were still millions of cases globally per year, many people were also very skeptical.”
The paper cites the globally felt disruption resulting from COVID-19 as presenting an opportunity for a concerted international effort. Critical to an eradication program’s success is establishing strong vaccine coverage and staying ahead of rapidly developing variants.
The paper — entitled, “We should not dismiss the possibility of eradicating COVID-19: Comparisons with smallpox and polio” — appears in BMJ Global Health.
The metrics of optimism
The authors of the paper define eradications as the “permanent reduction to zero of the worldwide incidence of infection caused by a specific agent as a result of deliberate efforts; intervention measures are no longer needed.”
The paper presents a preliminary assessment of the eradicability of COVID-19 by comparing it with other worldwide diseases, including smallpox, which has been eradicated, and polio, for which just one of three serotypes persists.
Based on an established scoring system and additional technical, sociopolitical, and economic factors that the authors included, the study compiled a total of 17 variables relating to vaccine-preventable diseases, with a three-point relative scale for each variable. Each of the diseases received a score according to these metrics, with higher values indicating a greater chance of eradication.
COVID-19 scored as being slightly more eradicable than polio.
Smallpox was most eradicable with a score of 2.7. In comparison, COVID-19 scored 1.6, and polio scored 1.5.
Medical challenges
Dr. Robert Kim-Farley, MPH, of the University of California, Los Angeles’s Fielding School of Public Health — who was not involved in writing the article — told MNT: “The single greatest obstacle to true eradication will be achieving and sustaining the very high vaccination coverage (using a vaccine with no or extremely low infection breakthrough) needed to achieve full herd immunity, whereby transmission of COVID-19 in a community ceases.”
Although he is not giving up on achieving higher vaccination coverage through more robust international public health and social measures, Dr. Wilson said that herd immunity is not a requirement for eradication.
“Smallpox was eradicated without achieving herd immunity,” said Dr. Wilson, “but rather by targeted vaccination approaches. It is also notable that countries have also eliminated measles without (quite) achieving herd immunity, and, in fact, the whole of the Americas eliminated measles for a time.”
The paper notes that there is also a “risk of the persistence of the pandemic virus in non-human animal reservoirs,” a phenomenon that is occurring with COVID-19 in the U.S. and elsewhere.
Asked whether current animal reservoirs may doom an eradication effort, Dr. Wilson said we are not there yet.
“If we had the situation of influenza viruses (widespread in wild birds) then obviously eradication would not be feasible,” he noted.
He added that “it is possible to eradicate diseases in some wild animals — for example, eliminating rabies in wild foxes via aerial bait drops containing vaccine (as per Western Europe).”
Dr. Kim-Farley cited what he sees as the three most significant obstacles to eradication success.
Current vaccines, noted Dr. Kim-Farley, “although offering excellent protection against severe illness and death, still have some breakthrough infections that can infect others.”
Identifying cases of often-asymptomatic COVID-19 is also harder, said Dr. Kim-Farley, than it is with smallpox and measles, which “are usually always symptomatic and identifiable.”
Finally, there is “the lack of political will to apply (and the unwillingness of some persons to accept) the strict public health measures, such as required vaccination, required mask wearing, required quarantine and isolation, and required testing.”
News
New research finds that subtle eye movements optimize vision
Our ability to see starts with the light-sensitive photoreceptor cells in our eyes. A specific region of the retina, termed fovea, is responsible for sharp vision. Here, the color-sensitive cone photoreceptors allow us to [...]
Scientists Were Wrong: Plants Absorb 31% More CO2 Than Previously Thought
New research shows plants absorb 31% more CO2 than previously estimated, raising the global GPP to 157 petagrams per year. Using carbonyl sulfide as a proxy for photosynthesis, this study highlights tropical rainforests’ critical role [...]
Doctors test first mRNA vaccine against norovirus
According to the Robert Koch Institute (RKI), the norovirus, which is widespread worldwide, is the cause of a large proportion of gastrointestinal infections. Those who catch the virus suffer from nausea, diarrhea and vomiting. [...]
Study reveals resistance of Pseudomonas aeruginosa to common cleaning agents
A new study reveals widespread resistance of a major bacterial pathogen to the active ingredients in cleaning agents commonly used in hospitals and homes. The American Chemical Society Infectious Diseases published the research, led [...]
AI’s Next Frontier: System 0 and the Future of Human Thought
“System 0” represents an emerging cognitive tool powered by AI that works alongside human intuition and analysis to enhance cognitive abilities. This new system promises to support complex decision-making and problem-solving but requires careful [...]
The Global Nanomedicine Market: Key Players and Emerging Technologies in Healthcare
This article provides an overview of the global nanomedicine market, highlighting key players, emerging technologies, and the challenges and opportunities that influence its growth and commercialization in the healthcare sector. Nanomedicines are nanotechnology-based drug products [...]
Scientists Have Discovered Toxic “Forever Chemicals” in Bottled Water
Scientists have found toxic PFAS in drinking water samples from around the world, with higher levels in tap water from China compared to the UK. Boiling water or using a filtration jug can reduce [...]
Urban Microbes Are Eating Disinfectants – Are We Fueling a New Health Threat?
New research reveals that microbes in urban environments are evolving to withstand the very cleaning agents designed to eliminate them. The study also uncovers new strains in Hong Kong, previously only found in the [...]
Startling Study Shows High-Potency Cannabis Alters DNA
The study shows that frequent use of high-potency cannabis alters DNA, affecting genes related to energy and immune function. These changes differ between those with and without psychosis, suggesting cannabis use could influence mental health through biological [...]
New nanotherapy targets artery inflammation in cardiovascular disease
Inflammation of the arteries is a primary precursor and driver of cardiovascular disease—the No. 1 killer of people in the United States. This inflammation is associated with the buildup of dangerous plaque inside the [...]
Revolutionary Nanoparticle Therapy for Prostate Cancer
A groundbreaking research effort involving teams from the University of Virginia, Mount Sinai, the University of Michigan, the University of Texas, and others has displayed the clinical efficacy of an innovative therapy that utilizes nanoparticles and [...]
Antibody engineering drives innovation in drug development
Monoclonal antibodies (mAbs) are used to prevent, detect, and treat a broad spectrum of non-communicable and communicable diseases. Over the past few years, the market for mAbs has grown exponentially with an expected compound [...]
Breakthrough Study Reveals How Bladder Cancer Starts and Spreads
Researchers found that DNA mutations from antiviral enzymes and chemotherapy fuel early bladder cancer, while abnormal circular DNA in tumor cells drives resistance to therapy. These discoveries open new therapeutic avenues. A groundbreaking study led by [...]
AI and Quantum Mechanics Accelerate Drug Discovery
A recent article published in the Journal of Chemical Information and Modeling researchers at Southern Methodist University (SMU) have developed SmartCADD, an open-source virtual tool designed to speed [...]
Targeting ‘undruggable’ diseases: Researchers reveal new levels of detail in targeted protein degradation
Researchers at the University of Dundee have revealed in the greatest detail yet the workings of molecules called protein degraders which can be deployed to combat what have previously been regarded as "undruggable" diseases, [...]
Revolutionizing Virology: AI Discovers Over 160,000 New RNA Viruses
Largest discovery of new virus species sheds light on the hidden virosphere. Artificial intelligence (AI) has been used to reveal details of a diverse and fundamental branch of life living right under our feet and in every [...]